Cristalius: A case in designer drugs

Military Medicine

Volumn 178, Issue 7, 2013, Pages

  Lenz, Jared ^a   Brown, Jaime ^a   Flagg, Seth ^a   Oh, Robert ^a   Batts, Kenneth ^a   Ditzler, Thomas ^a   Johnson, Jeremy ^a  

^a FORT BELVOIR COMMUNITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE; DESIGNER DRUG; DRUG DERIVATIVE; METHAMPHETAMINE;

ADDICTION; ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIZZINESS; FATIGUE; HUMAN; MALE; PATHOPHYSIOLOGY; SOLDIER; TACHYCARDIA; UNITED STATES; YOUNG ADULT;

ADULT; DESIGNER DRUGS; DIZZINESS; FATIGUE; HUMANS; MALE; METHAMPHETAMINE; MILITARY PERSONNEL; SUBSTANCE-RELATED DISORDERS; TACHYCARDIA; UNITED STATES; YOUNG ADULT;

EID: 84879700441     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-12-00393     Document Type: Article

References (13)

1. Newcombe R (editor): Mephedrone: The Use of Mephedrone (M-cat, Meow) in Middlesbrough. Manchester, UK, Lifeline Publications and Research, 2009. Available at http://www.lifelineprojectdev.co.uk/docs/M-cat%20report%20small.pdf; accessed December 1, 2010.
2. Fabrizio S, Albanese A, Fergus S, et al: Mephedrone (4-methylmethcathinone; 'meow-meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011; 14(3): 593-602. Available at http://www.springerlink.com/content/cl4g710287g76572/fulltext.pdf; accessed December 1, 2010.
3. Schmidt MM, Sharma A, Schifano F, Feinmann C: "Legal Highs" on the net-evaluation of UK-based Websites, products and product information. Forensic Sci Int 2011; 206: 92-7.
4. Brandt S, Sumnall H, Measham F, Cole J: Analysis of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal 2010; 2(8): 377-82.
5. Deluca P, Schifano F, Davey Z, et al: Mephedrone: Psychonaut Web Mapping Research Project (Last update: 1 March 2010). Available at http://www.psychonautproject.eu/documents/reports/Mephedrone.pdf; accessed December 1, 2010.
6. Erowid: 4-Methylmethcathinone (mephedrone, 4-MMC). http://www.erowid.org/chemicals/4_methylmethcathinone/4_methylmethcathinone.shtml.
7. Belhadj-Tahar H, Sadeg N: Methcathinone: a new postindustrial drug. Forensic Sci Int 2005; 153(1): 99-101.
8. Volkow ND, Fowler JS, Logan J, et al: Effects of modafinil on dopamine and dopamine transporters in the male human brain. JAMA 2009; 301(11): 1148-54.
9. Wood DM, Greene SL, Dargan PI: Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011; 28(4): 280-2.
10. Garrett G, Sweeney M: The serotonin syndrome as a result of mephedrone toxicity. BMJ Case Rep 2010.
11. Draper R: Serotonin syndrome, 2011. Available at http://www.patient.co.uk/doctor/Serotonin-Syndrome.htm; accessed December 1, 2010.
12. Ables A, Nagubilli R: Prevention, diagnosis, and management of serotonin syndrome. American family physician 2010; 81(9): 1139-42. Available at http://diamondl.ca/wrha/seminars/file.php?id=000355; accessed December 1, 2010.
13. Davies S, Wood DM, Smith G, et al: Purchasing "legal highs" on the internet-is there consistency in what you get? Q J Med 2010; 103: 489-93.